NEW YORK, Feb. 12 (GenomeWeb News) - Protein array company Zyomyx has raised $10 million in additional venture capital, the company said yesterday.
The financing round was led by CSFB Private Equity, which was joined by existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners, and Bio One Capital.
Zyomyx plans to use the funding to expand its line of products. The company wants to launch a murine cytokine biochip in April, followed by other biochips later this year.